HIV-1 natural viral suppressors: Control of viral replication in the absence of therapy

AIDS

Volumn 21, Issue 4, 2007, Pages 517-519

  Sajadi, Mohammad M ^a,b   Heredia, Alonso ^a   Le, Nhut ^a   Constantine, Neil T ^a   Redfield, Robert R ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; DNA EXTRACTION; GENE AMPLIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INFECTION CONTROL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

COHORT STUDIES; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PROVIRUSES; VIRAL LOAD; VIRUS REPLICATION;

EID: 33847011365     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328013d9eb     Document Type: Article

References (24)

1. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995; 332:209-216.
2. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332:201-208.
3. Candotii D, Costagliola D, Joberty C, Bonduelle O, Rouzioux C, Autran B, Agut H. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. J Med Virol 1999; 58:256-263.
4. Learmont J, Geczy A, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N Engl J Med 1999; 340:1715-1722.
5. Strathdee SA, Veuglers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, et al. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 1996; 10:959-656.
6. Schwartz D, Sharma U, Busch M, Weinhold K, Matthews T, Lieberman J, et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses 1994; 10:1703-1711.
7. Balotta C, Bagnarelli P, Riva C, Valenza A, Antinori S, Colombo MC, et al. Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. AIDS Res Hum Retroviruses 1997; 13:337-341.
8. Barker E, Mackewicz CE, Reyes-Teran G, Sato A, Stranford SA, Fujimura SH, et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998; 92:3105-3114.
9. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 1996; 156:2616-2623.
10. Zhang YJ, Fracasso C, Fiore JR, Bjorndal A, Angarano G, Gringeri A, Fenyo EM. Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. J Infect Dis 1997; 176:1180-1187.
11. Rusconi S, Berlusconi A, Papagno L, Colombo MC, DeMaddalena C, Riva A, et al. Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors. Clin Immunol Immunopathol 1997; 85:320-323.
12. Dyer WB, Ogg GS, Demoitie MA, Jin X, Geczy AF, Rowland-Jones SL, et al. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol 1999; 73:436-443.
13. Binley JM, Jin X, Huang Y, Zhang L, Cao Y, Ho DD, Moore JP. Persistent antibody responses but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA expression. J Virol 1998; 72:3472-3474.
14. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 1996; 12:585-592.
15. Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, et al. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses 1998; 14:117-121.
16. Petrucci A, Dorrucci M, Alliegro MB, Pezzotti P, Rezza G, Sinicco A, et al. How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS). J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:243-248.
17. Easterbrook PJ. Nonprogression in HIV infection. AIDS 1994; 8:1179-1182.
18. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4R T-cell levels. AIDS 1993; 7:1159-1166.
19. Kloosterboer N, Groeneveld P, Jansen C, van der Vorst TJ, Koning F, Winkel CN, et al. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus. Virology 2005; 339:70-80.
20. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005; 41:1053-1056.
21. Wei M, Xing H, Hong K, Huang H, Tang H, Qin G, Shao Y. Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor. AIDS 2004; 18:1863-1865.
22. Brostrom C, Visco-Comandini U, Yun Z, Sonnerborg A. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors. J Infect Dis 1999; 179:1542-1548.
23. Greenough TC, Brettler DB, Kirchhoff F, Alexander L, Desrosiers RC, O'Brien SJ, et al. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort. J Infect Dis 1999; 180:1790-1802.
24. Vesanen M, Stevens CE, Taylor PE, Rubinstein P, Saksela K. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol 1996; 70:9035-9040.